Understanding 2017 Summer Symposium James Collins
Exploring 2017 Summer Symposium James Collins reveals several interesting facts. "Synthetic biology and next-generation diagnostics"
Key Takeaways about 2017 Summer Symposium James Collins
- "Understanding transcription and splicing heterogeneity in cancer progression" Daniel Larson, Center for Cancer Research, ...
- James Collins
- Synthetic biology approaches to antimicrobial resistance.
- "Convergence in Health" Panelists: Marc N. Casper, President and CEO, Thermo Fisher Scientific Nancy Simonian, CEO, Syros ...
- "Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy" Chad A. Mirkin, Northwestern University Session III: ...
Detailed Analysis of 2017 Summer Symposium James Collins
For more about Introductory Remarks Tyler Jacks, Koch Institute, MIT http://ki.mit.edu/news/ Introductory Remarks Phillip A. Sharp, Koch Institute, MIT http://ki.mit.edu/news/
"New chemical engineering approaches to convergence" Robert S. Langer, Koch Institute, MIT Session III: Nanomedicine, ...
Stay tuned for more updates related to 2017 Summer Symposium James Collins.
